苏玉培, 潘昊, 刘丹丹, 王家辉, 丁平田, 潘卫三. 基于聚多巴胺特性构建的肿瘤靶向药物递送系统的研究进展J. 药学学报, 2022,57(1): 25-35. doi: 10.16438/j.0513-4870.2021-1151
引用本文: 苏玉培, 潘昊, 刘丹丹, 王家辉, 丁平田, 潘卫三. 基于聚多巴胺特性构建的肿瘤靶向药物递送系统的研究进展J. 药学学报, 2022,57(1): 25-35. doi: 10.16438/j.0513-4870.2021-1151
SU Yu-pei, PAN Hao, LIU Dan-dan, WANG Jia-hui, DING Ping-tian, PAN Wei-san. Advances in polydopamine-based drug delivery systems for tumor targetingJ. Acta Pharmaceutica Sinica, 2022,57(1): 25-35. doi: 10.16438/j.0513-4870.2021-1151
Citation: SU Yu-pei, PAN Hao, LIU Dan-dan, WANG Jia-hui, DING Ping-tian, PAN Wei-san. Advances in polydopamine-based drug delivery systems for tumor targetingJ. Acta Pharmaceutica Sinica, 2022,57(1): 25-35. doi: 10.16438/j.0513-4870.2021-1151

基于聚多巴胺特性构建的肿瘤靶向药物递送系统的研究进展

Advances in polydopamine-based drug delivery systems for tumor targeting

  • 摘要: 聚多巴胺(polydopamine,PDA)是受到贻贝中黏附蛋白启发而合成的一种新型聚合物,其具有良好的生物相容性、优异的光热转换性能、黏附性与高化学反应性和多重药物释放响应机制等天然优势,在肿瘤靶向药物递送系统中得到了广泛的应用。本综述就近年来基于PDA构建的药物递送系统在肿瘤靶向中的应用进行了总结,以期为构建更合理、更有效的基于PDA的多功能协同肿瘤治疗平台提供参考。

     

    Abstract: Polydopamine (PDA) is a novel type of polymer synthesized inspired by adhesion proteins in mussels. It has been widely used in tumor-targeting drug delivery systems due to its natural advantages such as good biocompatibility, excellent photothermal conversion performance, adhesion, high chemical reactivity and multiple drug release response mechanisms. This review summarizes the applications of PDA-based tumor-targeting drug delivery in recent years, hoping to provide references for designing a more reasonable and effective PDA-based multifunctional collaborative tumor therapy platform.

     

/

返回文章
返回